Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Rob Janknegt"'
Autor:
Anne G. R. Visser MD, Jos M. G. A. Schols MD,, Mathieu A. L. M. Prevoo MD, Rob Janknegt PhD, Bjorn Winkens PhD
Publikováno v:
Gerontology and Geriatric Medicine, Vol 7 (2021)
Introduction Polypharmacy is common in the frail nursing home population and associated with an increased risk of adverse events, unplanned hospitalizations, and increased all-cause mortality. Deprescribing using a deprescribing algorithm might reduc
Externí odkaz:
https://doaj.org/article/a1586c575c0347658d4e7130e11ff1bb
Autor:
Niels W. Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, Rob Janknegt, Ralph Peeters, Robert B. M. Landewé
Publikováno v:
RMD Open, Vol 5, Iss 1 (2019)
Objectives We aimed to evaluate the effects of methotrexate (MTX) comedication added to biological disease-modifying antirheumatic drugs (bDMARD) on disease activity measures in patients with rheumatoid arthritis (RA) in routine care.Methods Patients
Externí odkaz:
https://doaj.org/article/7627094e2afa4423b184d83c06b11e5d
Publikováno v:
American Journal of Health-System Pharmacy, 79(22), 2001-2011. American Society of Health-Systems Pharmacy
Purpose With the growing availability of biosimilars on the global market, clinicians and pharmacists have multiple off-patent biological products to choose from. Besides the competitiveness of the product’s price, other criteria should be consider
Publikováno v:
European Geriatric Medicine, 14, 51-57. Springer, Cham
PURPOSE: Both the coronavirus (COVID-19) disease and polypharmacy pose a serious threat to nursing home (NH) residents. This study aimed to assess the impact of polypharmacy on 30-day COVID-related mortality in NH residents with COVID-19.METHODS: Mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bae81db69657a37e7c7d95fef104667
https://cris.maastrichtuniversity.nl/en/publications/dfaf2951-4173-48da-81a2-895f24c61ff3
https://cris.maastrichtuniversity.nl/en/publications/dfaf2951-4173-48da-81a2-895f24c61ff3
Publikováno v:
Gerontology and Geriatric Medicine, Vol 7 (2021)
Gerontology and geriatric medicine, 7:23337214211050807. SAGE Publications Inc.
Gerontology and geriatric medicine, 7:23337214211050807. SAGE Publications Inc.
Introduction Polypharmacy is common in the frail nursing home population and associated with an increased risk of adverse events, unplanned hospitalizations, and increased all-cause mortality. Deprescribing using a deprescribing algorithm might reduc
Autor:
C. Houwen, L. Duijsens, Ralph Peeters, Robert Landewé, Niels Boone, Rob Janknegt, Mariëlle Romberg-Camps, A. A. van Bodegraven, Bjorn Winkens, L. Liu, P. H. M. van der Kuy
Publikováno v:
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer-Verlag
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, 74(5), 655-661. Springer Verlag
European Journal of Clinical Pharmacology, 74(5), 655-661. Springer-Verlag
European Journal of Clinical Pharmacology
European journal of clinical pharmacology, 74(5), 655-661. Springer Verlag
Background In clinical practice, non-medical switching of biological medication may provoke nocebo effects due to unexplained deterioration of therapeutic benefits. Indication extrapolation, idiosyncratic reactions, and interchangeability remain chal
Autor:
Fabienne J. H. Magdelijns, Jos M. G. A. Schols, P. Hugo M. Van Der Kuy, Wubbo J. Mulder, Rob Janknegt, Frans R.J. Verhey, Bjorn Winkens, Kim P G M Hurkens, Coen D.A. Stehouwer, Carlota Mestres-Gonzalvo, Hugo A. J. M. de Wit
Publikováno v:
International Journal of Hospital Pharmacy, 2(6), 1-12. eSciencePublisher
Introduction Medication reviews are an essential part of daily routine at a hospital ward but are prone to mistakes. With this study we want to assess the strengths and weaknesses of a Clinical Decision Support System (CDSS) and evaluate the addition
Autor:
Ralph Peeters, Alexandre Sepriano, Rob Janknegt, Paul Hugo Van Der Kuy, Niels Boone, Robert Landewé
Publikováno v:
RMD Open, 5(2):UNSP e001050. BMJ Publishing Group
RMD open, 5(2):e001050. BMJ Publishing Group
RMD Open
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
RMD Open, 5(2). BMJ PUBLISHING GROUP
RMD open, 5(2):e001050. BMJ Publishing Group
RMD Open
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
RMD Open, 5(2). BMJ PUBLISHING GROUP
ObjectiveTo test the longitudinal association between patient-reported outcome, Routine Assessment of Patient Index Data 3 (RAPID3) and the Disease Activity Score in 28 joints that includes the erythrocyte sedimentation rate (DAS28-ESR) in routine-ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a69f863af132ce0ba9a1981ea07fabc0
https://hdl.handle.net/1887/122656
https://hdl.handle.net/1887/122656
Autor:
Paul Hugo Van Der Kuy, Rob Janknegt, Robert Landewé, Niels Boone, Ralph Peeters, Alexandre Sepriano
Publikováno v:
RMD Open
RMD Open, 5(1). BMJ PUBLISHING GROUP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
RMD Open, 5(1):UNSP e000836. BMJ Publishing Group
RMD Open, 5(1). BMJ PUBLISHING GROUP
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
RMD Open, 5(1):UNSP e000836. BMJ Publishing Group
ObjectivesWe aimed to evaluate the effects of methotrexate (MTX) comedication added to biological disease-modifying antirheumatic drugs (bDMARD) on disease activity measures in patients with rheumatoid arthritis (RA) in routine care.MethodsPatients w
Autor:
Hugo A. J. M. de Wit, Frans R.J. Verhey, Kim P G M Hurkens, Rob Janknegt, Wubbo J. Mulder, Paul-Hugo M. van der Kuy, Carlota Mestres Gonzalvo, Bjorn Winkens, Jos M. G. A. Schols
Publikováno v:
International Journal of Clinical Pharmacy, 38(4), 915-923. Springer, Cham
Background A delirium is common in hospital settings resulting in increased mortality and costs. Prevention of a delirium is clearly preferred over treatment. A delirium risk prediction model can be helpful to identify patients at risk of a delirium,